Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö > Strategic Analysis of the U.S. Biopharmaceuticals Market
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1590)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (51)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (54)
¹ÙÀÌ¿ÀÀåºñ (357)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (131)
À¯ÀüÀÚ Ä¡·á/RNAi (101)
Àç»ýÀÇÇÐ (124)
Ç×ü/¸é¿ª (191)
½ÃÀ庸°í¼­

Strategic Analysis of the U.S. Biopharmaceuticals Market

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2008³â 12¿ù »óǰÄÚµå 78024
ÆäÀÌÁö Á¤º¸ 128 Pages
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This research service covers the strategic analysis of the U.S. biopharmaceutical market 2004-2014. Included are technology trends, total market revenue forecasts, and selected market segment revenue forecasts. The market is segmented by product class: antisense, cytokines and proteins, enzymes and hormones, gene and cell therapies, and vaccines. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipeline analysis.

Table of Contents

Table Of Contents

1. EXECUTIVE SUMMARY

  • Executive Summary
    • 1. Introduction

2. MARKET OVERVIEW

  • Research Scope and Methodology
    • 1. Scope and Segmentation
    • 2. Research Methodology
  • Market Introduction
    • 1. Measurements
    • 2. Introduction
    • 3. Main Classes of Biopharmaceuticals
    • 4. Recent Product Approvals
    • 5. Competitive Structure
  • Market Trends
    • 1. Hot Topics and Trends
    • 2. Industry Challenges
    • 3. Market Drivers
    • 4. Market Restraints
  • Pipeline Analysis
    • 1. Introduction
    • 2. Antisense Therapies
    • 3. Gene and Cell Therapies
    • 4. Hormones and Proteins
    • 5. Interferons and Interleukins
    • 6. Monoclonal Antibodies
    • 7. Vaccines
    • 8. Others

3. REVENUE ANALYSIS

  • Total Market Forecasts
    • 1. Revenue Forecasts
  • Select Sub Market Forecasts
    • 1. Introduction
    • 2. Monoclonal Antibodies Market Forecasts
    • 3. Human Growth Hormone Market Forecasts

4. DECISION SUPPORT DATABASES

  • Oncology Databases
    • 1. Cancer Cases
    • 2. Incidence of Breast Cancer
    • 3. Incidence of Colon and Rectum Cancer
    • 4. Incidence of Bladder Cancer
    • 5. Incidence of Lung Cancer
    • 6. Incidence of Stomach Cancer
  • Autoimmune and Inflammatory Disorders Databases
    • 1. Prevalence of Arthritis
    • 2. Prevalence of Psoriasis
    • 3. Prevalence of Multiple Sclerosis
  • Organ Transplants Databases
    • 1. The Total Number of Kidney Transplants
    • 2. Total Number of Heart Transplants
    • 3. Total Number of Liver Transplants
  • Cardiovascular Disorders
    • 1. Prevalence of Cardiovascular Diseases
    • 2. Prevalence of Coronary Heart Disease
    • 3. New Cases of Heart Attack
  • Neurodegenerative Disorders Databases
    • 1. Prevalence of Parkinson' s Disease
    • 2. Prevalence of Alzheimer' s Disease
    • 3. Prevalence of Epilepsy
    • 4. Incidence of Stroke
  • Respiratory Disorders Databases
    • 1. Prevalence of Asthma
    • 2. Prevalence of COPD
  • Miscellaneous Databases
    • 1. Age-Related Macular Degeneration Prevalence
    • 2. Incidence of Diabetes
Back to Top